skip to Main Content

Aphria and Tilray Combine to Create Largest Global Cannabis Company With Pro Forma Revenue of C$874 Million (US$685 Million)

PRESS RELEASE Complementary, Scalable Medical and Adult-Use Cannabis Businesses Strengthen Leadership Position in Canada; Expands U.S. and International Reach through World-Class Cultivation, Manufacturing, Diversified Product Portfolio and Distribution Footprint Robust Supply Chain and Operational Efficiencies Expected to Generate Approximately C$100…

Read More

Aphria Inc. Announces Executive Appointments and Transition

Press Release Leamington, Ontario – May 14, 2019 – Aphria Inc. (“Aphria” or the “Company”) (TSX:APHA and NYSE:APHA) a leading global cannabis company today announced several new executive appointments including James Meiers to the role of Chief Operating Officer, Aphria Leamington, Tim Purdie as Chief Information Officer & Chief Information Security Officer, and Maureen Berry as Vice President, Corporate Human…

Read More

Aphria Completes Acquisition of CC Pharma, Leading German Pharmaceutical and Medical Cannabis Distributor

PRESS RELEASE Leamington, Ontario – January 9, 2019 – Aphria Inc. (“Aphria” or the “Company”) (TSX: APH or US OTC: APHQF) today announced that it had completed its previously announced acquisition of CC Pharma GmbH (“CC Pharma”), a leading distributor of pharmaceutical products, including medical cannabis, to more than…

Read More
Back To Top
×Close search
Search